199 related articles for article (PubMed ID: 19026766)
1. Efficient identification and evaluation of effective Helicobacter pylori therapies.
Graham DY
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):145-8. PubMed ID: 19026766
[TBL] [Abstract][Full Text] [Related]
2. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
3. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
[TBL] [Abstract][Full Text] [Related]
4. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.
Graham DY; Lu H; Yamaoka Y
Drugs; 2008; 68(6):725-36. PubMed ID: 18416582
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
6. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
8. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
Branquinho D; Almeida N; Gregório C; Cabral JE; Casela A; Donato MM; Tomé L
BMC Gastroenterol; 2017 Feb; 17(1):31. PubMed ID: 28202013
[TBL] [Abstract][Full Text] [Related]
10. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749
[TBL] [Abstract][Full Text] [Related]
11. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication in Mexico with a levofloxacin-based scheme versus standard triple therapy: Results from an open-label, randomized, noninferiority phase iiib trial.
Ladrón-de-Guevara L; Bornstein-Quevedo L; González-Huezo S; Castañeda-Romero B; Costa FG; di Silvio-López M
Rev Gastroenterol Mex (Engl Ed); 2019; 84(3):274-283. PubMed ID: 30060902
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.
Puig I; Baylina M; Sánchez-Delgado J; López-Gongora S; Suarez D; García-Iglesias P; Muñoz N; Gisbert JP; Dacoll C; Cohen H; Calvet X
J Antimicrob Chemother; 2016 Oct; 71(10):2740-53. PubMed ID: 27342548
[TBL] [Abstract][Full Text] [Related]
14. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
Janssen MJ; Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
Aliment Pharmacol Ther; 2001 May; 15(5):613-24. PubMed ID: 11328254
[TBL] [Abstract][Full Text] [Related]
15. A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).
Marin AC; McNicholl AG; Gisbert JP
Expert Opin Pharmacother; 2013 May; 14(7):843-61. PubMed ID: 23537368
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of second-line regimens for
Chang YL; Tung YC; Tu YK; Yeh HZ; Yang JC; Hsu PI; Kim SE; Wu MF; Liou WS; Shiu SI
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32883715
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
Dehghani SM; Erjaee A; Imanieh MH; Haghighat M
Dig Dis Sci; 2009 Aug; 54(8):1720-4. PubMed ID: 19005755
[TBL] [Abstract][Full Text] [Related]
18. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
Prasertpetmanee S; Mahachai V; Vilaichone RK
Helicobacter; 2013 Aug; 18(4):270-3. PubMed ID: 23356886
[TBL] [Abstract][Full Text] [Related]
19. Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Chang YW; Ko WJ; Oh CH; Park YM; Oh SJ; Moon JR; Cho JH; Kim JW; Jang JY
Korean J Intern Med; 2019 Sep; 34(5):1022-1029. PubMed ID: 29898576
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
Matsumoto H; Shiotani A; Katsumata R; Fujita M; Nakato R; Murao T; Ishii M; Kamada T; Haruma K; Graham DY
Dig Dis Sci; 2016 Nov; 61(11):3215-3220. PubMed ID: 27659671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]